홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Dicyclohexylcarbodiimide → 3-(4-(4-(3-(1-Triphenylmethyl-4-imidazolyl)propanoyl)-piperazin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one

HRID 1167444
노트
인쇄 미리보기

반응식

HRID 1167444 반응식
[C:1]1([C:7]([C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)[N:8]2[CH:12]=[C:11]([CH2:13][CH2:14][C:15](O)=[O:16])[N:10]=[CH:9]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.C1(N=C=NC2CCCCC2)CCCCC1.ON1C2C=CC=CC=2N=N1.Cl.Cl.[N:57]1([C:63]2[CH:68]=[CH:67][C:66]([N:69]3[CH2:73][C@H:72]([CH2:74][O:75][C:76]4[CH:80]=[CH:79][O:78][N:77]=4)[O:71][C:70]3=[O:81])=[CH:65][C:64]=2[F:82])[CH2:62][CH2:61][NH:60][CH2:59][CH2:58]1.C(N(CC)C(C)C)(C)C>ClCCl>[C:24]1([C:7]([C:1]2[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=2)([C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][CH:23]=2)[N:8]2[CH:12]=[C:11]([CH2:13][CH2:14][C:15]([N:60]3[CH2:59][CH2:58][N:57]([C:63]4[CH:68]=[CH:67][C:66]([N:69]5[CH2:73][C@H:72]([CH2:74][O:75][C:76]6[CH:80]=[CH:79][O:78][N:77]=6)[O:71][C:70]5=[O:81])=[CH:65][C:64]=4[F:82])[CH2:62][CH2:61]3)=[O:16])[N:10]=[CH:9]2)[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 5

HCID 10868DicyclohexylcarbodiimideHCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 74084421-(Triphenylmethyl)-1H-imidazole-4-propanoic acidHCID 69980303HCID 69980303, 화합물

생성물 1

HCID 69979912
3-(4-(4-(3-(1-Triphenylmethyl-4-imidazolyl)propanoyl)-piperazin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one
수율 63.3%

시약·촉매·용매 1

HCID 6344Dichloromethane용매2회

실험 절차

3-(1-Triphenylmethyl-4-imidazolyl)propionic acid (420 mg, 1.1 mmol) was suspended in dichloromethane (10 ml) under nitrogen, and treated successively with dicyclohexylcarbodiimide (227 mg, 1.1 mmol) and 1-hydroxybenzotriazole (149 mg, 1.1 mmol), then stirred at ambient temperature for 30 minutes. To it was added a solution of 3-(4-(piperazin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one dihydrochloride (435 mg, 1 mmol) and N,N-diisopropylethylamine (258 mg, 2 mmol) in dichloromethane (5 ml). The mixture was stirred for 18 hours at the same temperature, solid filtered off, and the organic phase purified by chromatography on a 20 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 15% MeOH in dichloromethane. Relevant fractions were combined and evaporated to give the desired product (460 mg).

후처리

  1. stirringThe mixture was stirred for 18 hours at the same temperature, solid
  2. filtrationfiltered off
  3. customthe organic phase purified by chromatography on a 20 g silica Mega Bond Elut® column
  4. washeluting with a gradient
  5. temperatureincreasing in polarity from 0 to 15% MeOH in dichloromethane
  6. customevaporated

출처 및 근거

ORD 기록
ord-7d8f8c6bc6074053b9263a9b09300f61
출처 데이터셋
uspto-grants-2003_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06617339B1

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트